Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul-Sep;64(3):269-279.

Minimum inhibitory concentrations and resistance for selected antimicrobial agents (including imipenem, linezolid and tigecycline) of bacteria obtained from eye infections

Affiliations

Minimum inhibitory concentrations and resistance for selected antimicrobial agents (including imipenem, linezolid and tigecycline) of bacteria obtained from eye infections

Virgilio Galvis et al. Rom J Ophthalmol. 2020 Jul-Sep.

Abstract

Objective: To determine bacteria obtained from eye infections, both resistance and minimal inhibitory concentration (MIC) to gatifloxacin, moxifloxacin, tigecycline, linezolid and imipenem, in vitro. Methods: A cross-sectional descriptive study was undergone with 50 samples from 50 eyes of patients diagnosed with keratitis or endophthalmitis, who came to a consultation at the Fundación Oftalmológica de Santander (Floridablanca, Colombia) from August to November 2014. The MICs of the isolated microorganisms were established through Etest® strips (BioMérieux SA, Marcy-l'Etoile - France). Results: Of the 50 samples in total, 17 different bacteria species or groups were isolated. The main isolate for gram-positives was Methicillin Resistant Coagulase-Negative Staphylococcus (17 samples), and for gram-negatives was Pseudomonas aeruginosa (6 samples). The susceptibility percentages sorted from highest to lowest for gram-positive isolates (n=38) were: imipenem 90.3%, linezolid 87.9%, tigecycline 78.1%, gatifloxacin 68.8% and moxifloxacin 68.8%. For gram-negative isolates (n=12), they were: imipenem 72.7%, gatifloxacin 70%, moxifloxacin 66.7% (no reference cut-off points were found for Pseudomonas aeruginosa), tigecycline 22.2%, and linezolid 0% (as expected according to its inhibition spectrum). Conclusions: Although fourth generation fluoroquinolones are currently the preferred initial empirical monotherapy in our practice, given the increasing bacterial resistance, in cases in which gram-positive bacteria were isolated in the initial staining imipenem, linezolid or tigecycline could be used as an alternative. On the other hand, for cases of gram-negative bacteria, no antimicrobial susceptibility exceeded 80%, so using two antimicrobials looking for a synergy between them could be a better option. Abbreviations: S = Susceptibility, IS = Intermediate susceptibility, R = Resistance.

Keywords: Etest; antimicrobial resistance; endophthalmitis; infectious keratitis; minimum inhibitory concentration.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Etest® with gatifloxacin showing an ellipse of inhibition of microbial growth intersecting the scale on the strip at the point of 0.125 µg/ ml, representing that this value is the MIC of the antibacterial substance for this germ

Similar articles

Cited by

References

    1. Aslam B, Wang W, Arshad M, Khurshid M, Muzammil S, Rasool M, Nisar M, Alvi R, Aslam M, Qamar M, Salamat M, Baloch Z. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi: 10.2147/idr.s173867. - PMC - PubMed
    1. Thomas R, Melton R, Asbell P. Antibiotic resistance among ocular pathogens: current trends from the ARMOR surveillance study (2009-2016) Clin Optom (Auckl) 2019;11:15–26. doi: 10.2147/opto.s189115. - PMC - PubMed
    1. Asbell P, DeCory H. Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. PLoS One. 2018 doi:10.1371/journal.pone.020581. - PMC - PubMed
    1. Kowalski R, Yates K, Romanowski E, Karenchak L, Mah F, Gordon Y. An Ophthalmologist’s Guide to Understanding Antibiotic Susceptibility and Minimum Inhibitory Concentration Data. Ophthalmology. 2005;112:1987.e1–1987.e6. doi: 10.1016/j.ophtha.2005.06.025. - PubMed
    1. Khan Z, Siddiqui M, Park S. Current and Emerging Methods of Antibiotic Susceptibility Testing. Diagnostics (Basel) 2019;9:49. doi:10.3390/diagnostics9020049. - PMC - PubMed

MeSH terms

LinkOut - more resources